Australija - engleski - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - cefalexin monohydrate (equivalent: cefalexin, qty 250 mg) - capsule, hard - excipient ingredients: lactose monohydrate; magnesium stearate; gelatin; patent blue v; quinoline yellow; titanium dioxide; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - treatment of the following bacterial infections when caused by susceptible strains of the designated micro-organisms. respiratory tract infections: strep. pneumoniae and group a b-haemolytic streptococci. although penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections (including the prophylaxis of rheumatic fever), cephalexin is generally effective in the eradication of streptococci from the nasopharynx. substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present. bacterial sinusitis: streptococci, strep. pneumoniae and staph. aureus (methicillin sensitive only). otitis media: strep. pneumoniae, staphylococci (methicillin sensitive only). skin and skin structure infections: staphylococci (methicillin sensitive only) and/or streptococci. genitourinary tract infections, including acute prostatitis: e.coli, p.mirabilis, and klebsiella sp. the effectiveness of cephalexin in the treatment of bacterial infections of the brain and spinal column has not been established and cilex is not indicated in these conditions. note. appropriate culture and susceptibility tests should be initiated prior to and during therapy to determine susceptibility of the causative organism to cilex. renal function studies should be perfomed when indicated.

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - cephalexin monohydrate - unknown - cephalexin monohydrate antibiotic active 0.0 - active constituent

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

pharmachem australia pty ltd - cephalexin monohydrate - unknown - cephalexin monohydrate antibiotic active 0.0 - active constituent

Australija - engleski - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - cefalexin monohydrate -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - cefalexin monohydrate -

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

flynn pharma ltd - cefalexin - oral capsule - 250mg

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

flynn pharma ltd - cefalexin - oral capsule - 500mg

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

flynn pharma ltd - cefalexin - oral tablet - 250mg

Kanada - engleski - Health Canada

sivem pharmaceuticals ulc - cephalexin (cephalexin monohydrate) - tablet - 500mg - cephalexin (cephalexin monohydrate) 500mg - first generation cephalosporins

Australija - engleski - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - cephalexin; cefalexin -